Cargando…

Utilization of Cerebrospinal Fluid Proteome Analysis in the Diagnosis of Meningioma: A Systematic Review

Meningiomas have been classified as the most commonly occurring primary brain tumors. Although the majority of meningiomas are benign and slow-progressing, the tumors that grow to a larger size are associated with various risks during surgical procedures. Early detection of meningiomas is crucial to...

Descripción completa

Detalles Bibliográficos
Autores principales: Choudhary, Rabia, Elabbas, Adil, Vyas, Abhishek, Osborne, Darin, Chigurupati, Himaja Dutt, Abbas, Lawahiz F, Kampa, Prathima, M.H, Farzana, Sarwar, Hooria, Alfonso, Michael
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Cureus 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8710292/
https://www.ncbi.nlm.nih.gov/pubmed/34966627
http://dx.doi.org/10.7759/cureus.20707
_version_ 1784623120848519168
author Choudhary, Rabia
Elabbas, Adil
Vyas, Abhishek
Osborne, Darin
Chigurupati, Himaja Dutt
Abbas, Lawahiz F
Kampa, Prathima
M.H, Farzana
Sarwar, Hooria
Alfonso, Michael
author_facet Choudhary, Rabia
Elabbas, Adil
Vyas, Abhishek
Osborne, Darin
Chigurupati, Himaja Dutt
Abbas, Lawahiz F
Kampa, Prathima
M.H, Farzana
Sarwar, Hooria
Alfonso, Michael
author_sort Choudhary, Rabia
collection PubMed
description Meningiomas have been classified as the most commonly occurring primary brain tumors. Although the majority of meningiomas are benign and slow-progressing, the tumors that grow to a larger size are associated with various risks during surgical procedures. Early detection of meningiomas is crucial to the treatment as those detected early can be treated through non-invasive methods. Due to their benign nature, meningiomas contain homogeneous protein biomarkers that can be easily identified. Cerebrospinal fluid (CSF) has a high protein composition which can be used to diagnose various brain tumors. Because CSF comes into direct contact with the brain during its functioning, it is one of the factors that makes it an important source of different biomarkers. An analysis of biochemical changes occurring in the CSF can be useful in assessing the condition of the periventricular white matter and the parenchyma. In this review, PubMed, Medline, PubMed Central, and Google Scholar were used to identify studies discussing meningiomas regarding their assessment, types, diagnosis, and treatment, with more attention directed towards the application of CSF proteome analysis in diagnosis. Priority was given to studies published within the last 15 years. The following keywords were used in the literature search: “cerebrospinal fluid,” “meningiomas,” “brain tumors,” “primary brain tumors,” “protein biomarkers,” “proteome analysis,” and “diagnosis.” Subsequently, the 15 most relevant studies were selected for inclusion in the review. We excluded studies discussing different types of non-brain tumors as well as older articles. The selected studies also underwent a quality appraisal process using corresponding assessment tools. The selected articles were highly informative about meningiomas and the processes of diagnosis and treatment that are currently in use as well as those that are being developed or implemented. The use of CSF proteins in the diagnostic process is also discussed in this review. The studies also describe proteomics as a less invasive procedure that allows for the analysis of entire proteins and the projection of diagnostic images with higher resolutions that aid in the diagnosis.
format Online
Article
Text
id pubmed-8710292
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher Cureus
record_format MEDLINE/PubMed
spelling pubmed-87102922021-12-28 Utilization of Cerebrospinal Fluid Proteome Analysis in the Diagnosis of Meningioma: A Systematic Review Choudhary, Rabia Elabbas, Adil Vyas, Abhishek Osborne, Darin Chigurupati, Himaja Dutt Abbas, Lawahiz F Kampa, Prathima M.H, Farzana Sarwar, Hooria Alfonso, Michael Cureus Internal Medicine Meningiomas have been classified as the most commonly occurring primary brain tumors. Although the majority of meningiomas are benign and slow-progressing, the tumors that grow to a larger size are associated with various risks during surgical procedures. Early detection of meningiomas is crucial to the treatment as those detected early can be treated through non-invasive methods. Due to their benign nature, meningiomas contain homogeneous protein biomarkers that can be easily identified. Cerebrospinal fluid (CSF) has a high protein composition which can be used to diagnose various brain tumors. Because CSF comes into direct contact with the brain during its functioning, it is one of the factors that makes it an important source of different biomarkers. An analysis of biochemical changes occurring in the CSF can be useful in assessing the condition of the periventricular white matter and the parenchyma. In this review, PubMed, Medline, PubMed Central, and Google Scholar were used to identify studies discussing meningiomas regarding their assessment, types, diagnosis, and treatment, with more attention directed towards the application of CSF proteome analysis in diagnosis. Priority was given to studies published within the last 15 years. The following keywords were used in the literature search: “cerebrospinal fluid,” “meningiomas,” “brain tumors,” “primary brain tumors,” “protein biomarkers,” “proteome analysis,” and “diagnosis.” Subsequently, the 15 most relevant studies were selected for inclusion in the review. We excluded studies discussing different types of non-brain tumors as well as older articles. The selected studies also underwent a quality appraisal process using corresponding assessment tools. The selected articles were highly informative about meningiomas and the processes of diagnosis and treatment that are currently in use as well as those that are being developed or implemented. The use of CSF proteins in the diagnostic process is also discussed in this review. The studies also describe proteomics as a less invasive procedure that allows for the analysis of entire proteins and the projection of diagnostic images with higher resolutions that aid in the diagnosis. Cureus 2021-12-26 /pmc/articles/PMC8710292/ /pubmed/34966627 http://dx.doi.org/10.7759/cureus.20707 Text en Copyright © 2021, Choudhary et al. https://creativecommons.org/licenses/by/3.0/This is an open access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
spellingShingle Internal Medicine
Choudhary, Rabia
Elabbas, Adil
Vyas, Abhishek
Osborne, Darin
Chigurupati, Himaja Dutt
Abbas, Lawahiz F
Kampa, Prathima
M.H, Farzana
Sarwar, Hooria
Alfonso, Michael
Utilization of Cerebrospinal Fluid Proteome Analysis in the Diagnosis of Meningioma: A Systematic Review
title Utilization of Cerebrospinal Fluid Proteome Analysis in the Diagnosis of Meningioma: A Systematic Review
title_full Utilization of Cerebrospinal Fluid Proteome Analysis in the Diagnosis of Meningioma: A Systematic Review
title_fullStr Utilization of Cerebrospinal Fluid Proteome Analysis in the Diagnosis of Meningioma: A Systematic Review
title_full_unstemmed Utilization of Cerebrospinal Fluid Proteome Analysis in the Diagnosis of Meningioma: A Systematic Review
title_short Utilization of Cerebrospinal Fluid Proteome Analysis in the Diagnosis of Meningioma: A Systematic Review
title_sort utilization of cerebrospinal fluid proteome analysis in the diagnosis of meningioma: a systematic review
topic Internal Medicine
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8710292/
https://www.ncbi.nlm.nih.gov/pubmed/34966627
http://dx.doi.org/10.7759/cureus.20707
work_keys_str_mv AT choudharyrabia utilizationofcerebrospinalfluidproteomeanalysisinthediagnosisofmeningiomaasystematicreview
AT elabbasadil utilizationofcerebrospinalfluidproteomeanalysisinthediagnosisofmeningiomaasystematicreview
AT vyasabhishek utilizationofcerebrospinalfluidproteomeanalysisinthediagnosisofmeningiomaasystematicreview
AT osbornedarin utilizationofcerebrospinalfluidproteomeanalysisinthediagnosisofmeningiomaasystematicreview
AT chigurupatihimajadutt utilizationofcerebrospinalfluidproteomeanalysisinthediagnosisofmeningiomaasystematicreview
AT abbaslawahizf utilizationofcerebrospinalfluidproteomeanalysisinthediagnosisofmeningiomaasystematicreview
AT kampaprathima utilizationofcerebrospinalfluidproteomeanalysisinthediagnosisofmeningiomaasystematicreview
AT mhfarzana utilizationofcerebrospinalfluidproteomeanalysisinthediagnosisofmeningiomaasystematicreview
AT sarwarhooria utilizationofcerebrospinalfluidproteomeanalysisinthediagnosisofmeningiomaasystematicreview
AT alfonsomichael utilizationofcerebrospinalfluidproteomeanalysisinthediagnosisofmeningiomaasystematicreview